Biomerieux SA (BIOX.PA)
BIOX.PA on Paris Stock Exchange
74.50EUR
20 Aug 2019
74.50EUR
20 Aug 2019
Change (% chg)
-- (--)
-- (--)
Prev Close
€74.50
€74.50
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
101,928
101,928
52-wk High
€82.60
€82.60
52-wk Low
€53.10
€53.10
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Dec '18 | 1,252.10 | 1.030 |
| Jun '18 | 1,169.20 | 1.140 | |
| FY 2017 | Dec '17 | 1,153.90 | 1.162 |
| Jun '17 | 1,134.30 | 0.854 |
*Note: Units in Millions ofEuro
**Note: Units in Euro
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-19 | 2 | 1,965.75 | 2,583.00 | 1,348.50 | 1,939.20 |
| Quarter Ending Jun-20 | 1 | 1,338.50 | 1,338.50 | 1,338.50 | -- |
| Year Ending Dec-19 | 13 | 2,624.61 | 2,677.00 | 2,546.00 | 2,582.13 |
| Year Ending Dec-20 | 13 | 2,810.58 | 2,882.00 | 2,754.00 | 2,774.39 |
| Earnings (per share) | |||||
| Quarter Ending Dec-19 | 2 | 1.70 | 2.09 | 1.31 | 1.65 |
| Year Ending Dec-19 | 13 | 2.32 | 2.42 | 2.21 | 2.32 |
| Year Ending Dec-20 | 13 | 2.63 | 2.74 | 2.40 | 2.58 |
| LT Growth Rate (%) | 3 | 9.70 | 10.90 | 8.90 | 12.95 |
Sales and Profit Figures in Euro (EUR);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 35.41 | 33.28 | 33.85 | |
| P/E High - Last 5 Yrs. | 39.24 | 39.00 | 54.29 | |
| P/E Low - Last 5 Yrs. | 25.07 | 24.36 | 28.22 | |
| Beta | 0.45 | 0.79 | 0.99 | |
| Price to Sales (TTM) | 3.76 | 6.58 | 7.90 | |
| Price to Book (MRQ) | 4.69 | 5.80 | 4.38 | |
| Price to Tangible Book (MRQ) | 11.29 | 7.98 | 5.07 | |
| Price to Cash Flow (TTM) | 21.19 | 23.71 | 23.70 | |
| % Owned Institutions | -- | 4.84 | 1.78 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | 0.46 | 1.01 | 1.67 | |
| Dividend Yield - 5 Year Avg | 0.69 | 1.11 | 1.37 | |
| Dividend 5 Year Growth Rate | 0.98 | 11.90 | 6.82 | |
| Payout Ratio(TTM) | 16.13 | 29.73 | 46.67 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 8.51 | 5.15 | 14.65 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 5.82 | 4.83 | 8.45 | |
| Sales - 5 Yr. Growth Rate | 8.80 | 7.38 | 9.43 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -11.31 | 45.15 | 19.40 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 7.65 | -- | -- | |
| EPS - 5 Yr. Growth Rate | 9.37 | 16.06 | 7.15 | |
| Capital Spending - 5 Yr. Growth Rate | 11.59 | 8.34 | 8.01 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 1.16 | 2.51 | 2.52 |
| Current Ratio (MRQ) | 1.71 | 3.24 | 3.52 |
| LT Debt to Equity (MRQ) | 23.16 | 18.41 | 12.61 |
| Total Debt to Equity (MRQ) | 28.35 | 22.50 | 17.64 |
| Interest Coverage (TTM) | 13.63 | 90.88 | 14.93 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 53.78 | 60.62 | 50.25 | |
| Gross Margin - 5 Yr. Avg. | 51.97 | 60.58 | 51.36 | |
| EBITD Margin (TTM) | 21.37 | -- | -- | |
| EBITD - 5 Yr. Avg | 20.17 | 24.57 | 16.42 | |
| Operating Margin (TTM) | 14.19 | 14.56 | -6.97 | |
| Operating Margin - 5 Yr. Avg. | 12.83 | 17.96 | 11.87 | |
| Pre-Tax Margin (TTM) | 13.24 | 14.21 | -7.30 | |
| Pre-Tax Margin - 5 Yr. Avg. | 11.80 | 17.82 | 15.72 | |
| Net Profit Margin (TTM) | 10.55 | 9.93 | -11.11 | |
| Net Profit Margin - 5 Yr. Avg. | 8.78 | 13.22 | 11.11 | |
| Effective Tax Rate (TTM) | 20.34 | 22.29 | 20.61 | |
| Effective Tax Rate - 5 Yr. Avg. | 25.64 | 24.87 | 24.51 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 218,253 | 26,823,467 | 870,638,159 | |
| Net Income/Employee (TTM) | 23,021 | 3,176,467 | 101,855,832 | |
| Receivable Turnover (TTM) | 5.10 | 4.77 | 5.88 | |
| Inventory Turnover (TTM) | 2.81 | 3.02 | 3.66 | |
| Asset Turnover (TTM) | 0.76 | 0.74 | 0.85 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | 8.01 | 10.96 | 10.25 | |
| Return on Assets - 5 Yr. Avg. | 6.49 | 10.20 | 11.17 | |
| Return on Investment (TTM) | 10.43 | 14.10 | 12.69 | |
| Return on Investment - 5 Yr. Avg. | 8.53 | 13.03 | 14.15 | |
| Return on Equity (TTM) | 14.00 | 64.83 | 17.13 | |
| Return on Equity - 5 Yr. Avg. | 11.74 | 16.72 | 15.53 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 5.82 | 7.22 | 8.80 |
| EPS (TTM) % | 7.66 | 32.46 | 9.37 |
| Dividend % | 2.94 | 1.64 | 0.98 |
Note: Units in Millions of US Dollars
Performance for Biomerieux SA
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 2.40 | 1.10 | 99 | 80 |
| 13 Week | 6.80 | 6.03 | 99 | 85 |
| 26 Week | 17.85 | 3.48 | 99 | 91 |
| 52 Week | 3.90 | 1.50 | 99 | 68 |
| YTD | 29.74 | 9.40 | 99 | 87 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 19.44% |
| # of Holders: | 238 |
| Total Shares Held: | 23,010,556 |
| 3 Mo. Net Change: | -28,690 |
| # New Positions: | 6 |
| # Closed Positions: | 3 |
| # Increased Positions: | 50 |
| # Reduced Positions: | 56 |
| # Net Buyers: | -6 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.